DICE Therapeutics, Inc.
DICE · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35 | -$26 | -$23 | -$21 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $5 | $3 | $3 |
| Change in WC | $3 | $0 | $1 | $1 |
| Other Non-Cash | -$3 | -$2 | $0 | $0 |
| Operating Cash Flow | -$29 | -$22 | -$18 | -$15 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$54 | -$398 | -$45 | -$29 |
| Inv. Sales/Matur. | $55 | $60 | $106 | $77 |
| Other Inv. Act. | $0 | $0 | $45 | $0 |
| Investing Cash Flow | -$1 | -$338 | $106 | $47 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $324 | $0 |
| Stock Repurch. | $4,828 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4,828 | $0 | $325 | -$0 |
| Financing Cash Flow | $1 | $0 | $325 | -$0 |
| Forex Effect | $4,856 | $0 | $0 | $0 |
| Net Chg. in Cash | -$28 | -$360 | $413 | $32 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $102 | $462 | $48 | $17 |
| End Cash | $74 | $102 | $462 | $48 |
| Free Cash Flow | -$30 | -$23 | -$18 | -$16 |